Patrick Martin

737 total citations
40 papers, 561 citations indexed

About

Patrick Martin is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Patrick Martin has authored 40 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Surgery. Recurrent topics in Patrick Martin's work include Attention Deficit Hyperactivity Disorder (13 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Bipolar Disorder and Treatment (6 papers). Patrick Martin is often cited by papers focused on Attention Deficit Hyperactivity Disorder (13 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Bipolar Disorder and Treatment (6 papers). Patrick Martin collaborates with scholars based in United States, United Kingdom and Japan. Patrick Martin's co-authors include James Ermer, Mary Corcoran, Mary Buckwalter, Katarina Ilić, Ivy Song, Michael Smyth, David M. Pierce, Phillip Wang, Hong Wan and William B. Smith and has published in prestigious journals such as Gastroenterology, Journal of Allergy and Clinical Immunology and The American Journal of Gastroenterology.

In The Last Decade

Patrick Martin

40 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Martin United States	15	175	98	93	91	82	40	561
Bradley Vince United States	12	62 0.4×	52 0.5×	79 0.8×	55 0.6×	34 0.4×	29	452
Brian L. Lloyd Australia	13	47 0.3×	98 1.0×	45 0.5×	60 0.7×	38 0.5×	36	705
Beate Rohde Germany	16	360 2.1×	38 0.4×	25 0.3×	49 0.5×	11 0.1×	45	1000
Mark S. Luer United States	16	61 0.3×	125 1.3×	66 0.7×	79 0.9×	8 0.1×	27	592
B Astruc France	9	78 0.4×	74 0.8×	154 1.7×	47 0.5×	7 0.1×	21	689
J. Laidlaw United Kingdom	14	135 0.8×	75 0.8×	146 1.6×	60 0.7×	24 0.3×	18	652
M Imler France	13	175 1.0×	53 0.5×	59 0.6×	31 0.3×	24 0.3×	67	587
Giovanni Pinelli Italy	11	112 0.6×	53 0.5×	60 0.6×	88 1.0×	5 0.1×	23	348
Eva‐Maria Paulus Germany	10	113 0.6×	120 1.2×	50 0.5×	15 0.2×	25 0.3×	20	506
M J Brodie United Kingdom	18	392 2.2×	89 0.9×	34 0.4×	132 1.5×	17 0.2×	34	974

Countries citing papers authored by Patrick Martin

Since Specialization

Citations

This map shows the geographic impact of Patrick Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Martin more than expected).

Fields of papers citing papers by Patrick Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Martin. The network helps show where Patrick Martin may publish in the future.

Co-authorship network of co-authors of Patrick Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Martin. A scholar is included among the top collaborators of Patrick Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Martin. Patrick Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Patrick, et al.. (2020). <p>Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma</p>. Clinical ophthalmology. Volume 14. 885–896. 7 indexed citations

Childress, Ann, Robert L. Findling, James X. Wu, et al.. (2020). Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 30(3). 128–136. 9 indexed citations

Yu, Ming, et al.. (2019). Effects of Food on the Bioavailability of Amphetamine in Healthy Adults After Administration of SHP465 Mixed Amphetamine Salts Extended-Release Capsules. Drugs in R&D. 19(2). 167–175. 2 indexed citations

Palmer, Melissa, L. J. JENNINGS, Debra G. Silberg, Caleb Bliss, & Patrick Martin. (2018). A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis. BMC Pharmacology and Toxicology. 19(1). 10–10. 26 indexed citations

Smith, William B., et al.. (2016). Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study. Clinical Autonomic Research. 26(4). 269–277. 33 indexed citations

Ermer, James, Mary Corcoran, & Patrick Martin. (2015). Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover Study. Drugs in R&D. 15(2). 175–185. 16 indexed citations

Knebel, William, et al.. (2014). Population Pharmacokinetic/Pharmacodynamic Modeling of Guanfacine Effects on QTc and Heart Rate in Pediatric Patients. The AAPS Journal. 16(6). 1237–1246. 6 indexed citations

Pierce, David M., Mary Corcoran, Patrick Martin, et al.. (2014). Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials. Drug Design Development and Therapy. 8. 529–529. 9 indexed citations

Martin, Patrick, Bryan Dirks, Lev Gertsik, et al.. (2014). Safety and Pharmacokinetics of Lisdexamfetamine Dimesylate in Adults With Clinically Stable Schizophrenia. Journal of Clinical Psychopharmacology. 34(6). 682–689. 14 indexed citations

10.

Ermer, James, et al.. (2013). An Open-Label Investigation of the Pharmacokinetic Profiles of Lisdexamfetamine Dimesylate and Venlafaxine Extended-Release, Administered Alone and in Combination, in Healthy Adults. Clinical Drug Investigation. 33(4). 243–254. 15 indexed citations

11.

Corcoran, Mary, et al.. (2013). Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release. Drugs in R&D. 13(1). 53–61. 13 indexed citations

12.

Besses, Carlos, W. Zeller, Alberto Álvarez‐Larrán, et al.. (2012). Pharmacokinetics and tolerability of anagrelide hydrochloride in young (18 50 years) and elderly (? 65 years) patients with essential thrombocythemia. International Journal of Clinical Pharmacology and Therapeutics. 50(11). 787–796. 8 indexed citations

13.

Martin, Patrick, Anthony Croft, Alissa Walsh, et al.. (2012). Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy. Colorectal Disease. 15(3). 374–379. 19 indexed citations

14.

Pierce, David M., et al.. (2012). Assessment of Pharmacodynamic Equivalence and Tolerability of Lanthanum Carbonate Oral Powder and Tablet Formulations: A Single-Center, Randomized, Open-Label, 2-Period Crossover Study in Healthy Subjects. Clinical Therapeutics. 34(6). 1290–1300.e2. 12 indexed citations

15.

Martin, Patrick, et al.. (2011). Comparison of Dietary Phosphate Absorption After Single Doses of Lanthanum Carbonate and Sevelamer Carbonate in Healthy Volunteers: A Balance Study. American Journal of Kidney Diseases. 57(5). 700–706. 33 indexed citations

16.

Ermer, James, W Döll, Patrick Martin, et al.. (2011). Pharmacokinetics of Lisdexamfetamine Dimesylate after Targeted Gastrointestinal Release or Oral Administration in Healthy Adults. Drug Metabolism and Disposition. 40(2). 290–297. 18 indexed citations

17.

Pierce, David M., Stuart Hossack, Lona Poole, et al.. (2010). The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol. Nephrology Dialysis Transplantation. 26(5). 1615–1621. 29 indexed citations

18.

Ermer, James, et al.. (2010). Lisdexamfetamine Dimesylate: Linear Dose‐Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open‐Label Single‐Dose Pharmacokinetic Study in Healthy Adult Volunteers. The Journal of Clinical Pharmacology. 50(9). 1001–1010. 64 indexed citations

19.

Metz, David C., Vijaya S. Pratha, Patrick Martin, et al.. (2000). Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease. The American Journal of Gastroenterology. 95(3). 626–633. 42 indexed citations

20.

Boni, Joseph, Joan Korth‐Bradley, Patrick Martin, et al.. (1999). Pharmacokinetics of etodolac in patients with stable juvenile rheumatoid arthritis. Clinical Therapeutics. 21(10). 1715–1724. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact